Serbia

Reimbursed Care Access

Serbia classifies psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X and most classical psychedelics as controlled psychotropic/narcotic substances under national law; they have no authorised medical use outside of approved research. Ketamine is widely used and accepted within Serbian medical practice as an anaesthetic and analgesic (and thereby available in hospitals and clinics), but esketamine (Spravato®) does not appear to have a Serbian national marketing authorisation and is not part of publicly reimbursed mental‑health formularies. Access to other agents (ibogaine, ayahuasca/plant brews) is likewise prohibited except within formal clinical research or extremely limited, legally risky contexts.